Indigenous women living “off reserve” face many disparities in health care access

The FDA and Apel­lis Phar­ma­ceu­ti­cals have up­dat­ed the la­bel for Syfovre — an in­jec­tion for late-stage wet age-re­lat­ed mac­u­lar de­gen­er­a­tion — to ad­dress the po­ten­tial

Plus, news about In­tel­lia and Re­Code: KalVista aims to raise $160M fol­low­ing piv­otal read­out: Ear­li­er this week, the com­pa­ny said its oral drug for hered­i­tary